181 related articles for article (PubMed ID: 8387542)
21. Down-regulation of insulin-like growth factor binding proteins and growth modulation in hepatoma cells by retinoic acid.
Kim DG; Lee DY; Cho BH; You KR; Kim MY; Ahn DS
Hepatology; 1999 Apr; 29(4):1091-8. PubMed ID: 10094952
[TBL] [Abstract][Full Text] [Related]
22. Monocyte-macrophage release of IL-1 is inhibited by type-1 plasminogen activator inhibitors.
Robson SC; Saunders R; Kirsch RE
J Clin Lab Immunol; 1990 Oct; 33(2):83-90. PubMed ID: 1967070
[TBL] [Abstract][Full Text] [Related]
23. Augmentation of arterial endothelial cell expression of the plasminogen activator inhibitor type-1 (PAI-1) gene by proinsulin and insulin in vivo.
Nordt TK; Sawa H; Fujii S; Bode C; Sobel BE
J Mol Cell Cardiol; 1998 Aug; 30(8):1535-43. PubMed ID: 9737940
[TBL] [Abstract][Full Text] [Related]
24. Rhein inhibits transforming growth factor beta1 induced plasminogen activator inhibitor-1 in endothelial cells.
Zhu J; Liu Z; Huang H; Chen Z; Li L
Chin Med J (Engl); 2003 Mar; 116(3):354-9. PubMed ID: 12781036
[TBL] [Abstract][Full Text] [Related]
25. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
26. Differential regulation by troglitazone of plasminogen activator inhibitor type 1 in human hepatic and vascular cells.
Nordt TK; Peter K; Bode C; Sobel BE
J Clin Endocrinol Metab; 2000 Apr; 85(4):1563-8. PubMed ID: 10770198
[TBL] [Abstract][Full Text] [Related]
27. De novo synthesis of diacylglycerol in endothelium may mediate the association between PAI-1 and the insulin resistance syndrome.
McCarty MF
Med Hypotheses; 2005; 64(2):388-93. PubMed ID: 15607575
[TBL] [Abstract][Full Text] [Related]
28. Nox4 mediates the expression of plasminogen activator inhibitor-1 via p38 MAPK pathway in cultured human endothelial cells.
Jaulmes A; Sansilvestri-Morel P; Rolland-Valognes G; Bernhardt F; Gaertner R; Lockhart BP; Cordi A; Wierzbicki M; Rupin A; Verbeuren TJ
Thromb Res; 2009 Sep; 124(4):439-46. PubMed ID: 19540572
[TBL] [Abstract][Full Text] [Related]
29. Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1.
Tan BK; Adya R; Chen J; Farhatullah S; Heutling D; Mitchell D; Lehnert H; Randeva HS
Cardiovasc Res; 2009 Aug; 83(3):566-74. PubMed ID: 19414528
[TBL] [Abstract][Full Text] [Related]
30. Growth state-dependent regulation of plasminogen activator inhibitor type-1 gene expression during epithelial cell stimulation by serum and transforming growth factor-beta1.
Boehm JR; Kutz SM; Sage EH; Staiano-Coico L; Higgins PJ
J Cell Physiol; 1999 Oct; 181(1):96-106. PubMed ID: 10457357
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of metformin on insulin and glucagon action in rat hepatocytes involve post-receptor alterations.
Alengrin F; Grossi G; Canivet B; Dolais-Kitabgi J
Diabete Metab; 1987; 13(6):591-7. PubMed ID: 3329121
[TBL] [Abstract][Full Text] [Related]
32. Effect of insulin receptor down regulation on insulin-stimulated thymidine incorporation in cultured human fibroblasts and tumor cell lines.
Mountjoy KG; Holdaway IM
Cancer Biochem Biophys; 1991 Aug; 12(2):117-26. PubMed ID: 1769008
[TBL] [Abstract][Full Text] [Related]
33. Metformin and insulin receptors.
Vigneri R; Gullo D; Pezzino V
Diabetes Care; 1984; 7 Suppl 1():113-7. PubMed ID: 6376023
[TBL] [Abstract][Full Text] [Related]
34. Constitutive biosynthesis of plasminogen activator inhibitor type-1 (PAI-1) by cultured human aortic endothelial cells independent of insulin.
Klassen KJ; Nordt TK; Schneider DJ; Sobel BE
Coron Artery Dis; 1993 Aug; 4(8):713-9. PubMed ID: 8261243
[TBL] [Abstract][Full Text] [Related]
35. Attenuation by gemfibrozil of expression of plasminogen activator inhibitor type 1 induced by insulin and its precursors.
Nordt TK; Kornas K; Peter K; Fujii S; Sobel BE; Kübler W; Bode C
Circulation; 1997 Feb; 95(3):677-83. PubMed ID: 9024157
[TBL] [Abstract][Full Text] [Related]
36. Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease.
Nordt TK; Schneider DJ; Sobel BE
Circulation; 1994 Jan; 89(1):321-30. PubMed ID: 8281664
[TBL] [Abstract][Full Text] [Related]
37. PAI-1 synthesis in the human hepatoma cell line HepG2 is increased by cytokines--evidence that the liver contributes to acute phase behaviour of PAI-1.
de Boer JP; Abbink JJ; Brouwer MC; Meijer C; Roem D; Voorn GP; Lambers JW; van Mourik JA; Hack CE
Thromb Haemost; 1991 Feb; 65(2):181-5. PubMed ID: 1711245
[TBL] [Abstract][Full Text] [Related]
38. Metformin enhances insulin binding to "in vitro" down regulated human fat cells.
Cigolini M; Zancanaro C; Benati D; Cavallo E; Bosello O; Smith U
Diabete Metab; 1987 Feb; 13(1):20-2. PubMed ID: 3552772
[TBL] [Abstract][Full Text] [Related]
39. Selective suppression of insulin-induced proliferation of cultured human hepatoma cells by somatostatin.
Chou CK; Ho LT; Ting LP; Hu CP; Su TS; Chang WC; Suen CS; Huang MY; Chang CM
J Clin Invest; 1987 Jan; 79(1):175-8. PubMed ID: 2878937
[TBL] [Abstract][Full Text] [Related]
40. Differential mechanisms targeting type 1 plasminogen activator inhibitor and vitronectin into the storage granules of a human megakaryocytic cell line.
Hill SA; Shaughnessy SG; Joshua P; Ribau J; Austin RC; Podor TJ
Blood; 1996 Jun; 87(12):5061-73. PubMed ID: 8652819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
